Avoid common mistakes on your manuscript.
Correction to: Journal of Neurology https://doi.org/10.1007/s00415-023-11910-z.
In the original version of this article, mistakes were noticed in Table 1 and Table 2.
In the Table 1, text in the column “Application” and row “Ravulizumab” which previously read:
i. v., weight-based2, loading dose of 2400–3000 mg on days 1 and 15 followed by 3000–3600 mg once every 8 weeks.
Should have read:
i. v., weight-based2, loading dose of 2400–3000 mg on day 1 followed by the maintenance dose (3000–3600 mg) after 2 weeks and then once every 8 weeks.
In the Table 2, text in the column “Inclusion criteria” and row “Ravulizumab” which previously read:
≥ 2 attacks in 12 months or ≥ 3 attacks in 24 months with 1 attack in the last 12 months.
Should have read:
≥ 1 relapse in the last 12 months.
Author information
Authors and Affiliations
Consortia
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kümpfel, T., Giglhuber, K., Aktas, O. et al. Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management. J Neurol 271, 3702–3707 (2024). https://doi.org/10.1007/s00415-024-12288-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-024-12288-2